LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance
Author:
Xiangyu Zhai,Zhijia Xia,Gang Du,Xinlu Zhang,Tong Xia,Delin Ma,Xiaosong Li,Bin Jin,Hao Zhang
Publication:
Genes & Diseases
© 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.